LOGIN
No significant analgesic benefit of liposomal bupivacaine over bupivacaine HCl for PAI in TJA
September 2017
No significant analgesic benefit of liposomal bupivacaine over bupivacaine HCl for PAI in TJA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial
J Arthroplasty. 2017 Feb;32(2):628-634Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
162 patients scheduled for total knee arthroplasty were randomized to postoperative analgesia using periarticular injection analgesia containing either liposomal bupivacaine or standard bupivacaine HCl. The purpose of this study was to determine if the use of liposomal bupivacaine was associated with significantly lower perioperative pain scores. Results demonstrated no significant differences bet...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.